Guardant Health
GH
#1605
Rank
NZ$22.54 B
Marketcap
NZ$173.56
Share price
2.03%
Change (1 day)
106.78%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

We have found no dividend yield history for this company